{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:58:27Z","timestamp":1782356307597,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The purpose of this systematic review and meta-analysis is to explore the utilization of cardioprotective medications in patients treated with RT and assess their impact on cardiovascular and cerebrovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials\/methods<\/jats:title>\n                    <jats:p>A literature search of PubMed, Embase and Scopus was performed in March 2025. Studies of adult patients treated with RT to the head and neck or thoracic regions which investigated the effects of cardioprotective medications (defined as anti-hypertensives, lipid-lowering therapies or anti-thrombotic medications) on the incidence of cardiovascular or cerebrovascular events were eligible for inclusion. Studies that reported the proportion of patients treated with RT who were utilizing cardioprotective medications as recommended by CVD guidelines were also included. Meta-analysis was performed using R with a random effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 10 retrospective studies which were eligible for inclusion. Five of the ten studies included patients with head and neck cancer only, whilst two studies included patients with lung cancer and one study included patients with breast cancer alone. Meta-analysis of three studies suggested that patients treated with RT who received statin therapy had a reduced risk of cerebrovascular events (stroke or transient ischemic attack), with a relative risk of 0.74 (95% CI 0.60-0.90). There was no difference in major adverse cardiac events (MACE) for patients treated with RT to the head and neck or thoracic regions who received statin therapy compared to those who did not (relative risk 0.99, 95% CI 0.67 to 1.46, n = 5 studies). A meta-analysis of four studies suggested that 59% (95% CI 35% to 80%) of patients treated with RT not on statin therapy had indications for commencement of these medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence exploring the impact of cardioprotective medications on CVD risk in patients treated with RT is heterogenous and limited to retrospective non-randomized studies. A considerable proportion of patients undergoing RT are not being prescribed cardioprotective medications as suggested by existing CVD guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40959-025-00439-x","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:44:29Z","timestamp":1767847469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardioprotective medications and the incidence of cardiovascular events in patients treated with radiotherapy: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Vishwa","family":"Pakeerathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Marwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rahman","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"439_CR1","unstructured":"Majeed H, Gupta V. Adverse effects of radiation therapy. StatPearls. 2025."},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"652761","DOI":"10.3389\/fcvm.2021.652761","volume":"8","author":"EH Yang","year":"2021","unstructured":"Yang EH, Marmagkiolis K, Balanescu DV, et al. Radiation-Induced vascular Disease-A State-of-the-Art review. Front Cardiovasc Med. 2021;8:652761. https:\/\/doi.org\/10.3389\/fcvm.2021.652761.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"439_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ohn.1249","volume":"173","author":"E Liew","year":"2025","unstructured":"Liew E, Tan JX, Low CE, et al. Stroke risk in head and neck cancer: A Meta-analysis of reconstructed individual patient survival data. Otolaryngol Head Neck Surg Jul. 2025;173(1):17\u201326. https:\/\/doi.org\/10.1002\/ohn.1249.","journal-title":"Otolaryngol Head Neck Surg Jul"},{"issue":"1","key":"439_CR4","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1186\/s12885-024-13281-8","volume":"20","author":"M Locquet","year":"2024","unstructured":"Locquet M, Jacob S, Geets X, Beaudart C. Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis. BMC Cancer Dec. 2024;20(1):1556. https:\/\/doi.org\/10.1186\/s12885-024-13281-8.","journal-title":"BMC Cancer Dec"},{"issue":"10","key":"439_CR5","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang X, Palaskas NL, Yusuf SW, et al. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J Thorac Oncol Oct. 2020;15(10):1682\u201390. https:\/\/doi.org\/10.1016\/j.jtho.2020.06.014.","journal-title":"J Thorac Oncol Oct"},{"key":"439_CR6","doi-asserted-by":"publisher","unstructured":"Siaravas KC, Katsouras CS, Sioka C. Radiation treatment mechanisms of cardiotoxicity: A systematic review. Int J Mol Sci Mar. 2023;27(7). https:\/\/doi.org\/10.3390\/ijms24076272.","DOI":"10.3390\/ijms24076272"},{"key":"439_CR7","doi-asserted-by":"publisher","unstructured":"O\u2019Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med. Jan 2008;121(1):24\u201333. https:\/\/doi.org\/10.1016\/j.amjmed.2007.06.033.","DOI":"10.1016\/j.amjmed.2007.06.033"},{"issue":"8","key":"439_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","volume":"23","author":"USPST Force","year":"2022","unstructured":"Force USPST, Mangione CM, Barry MJ, et al. Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement. JAMA Aug. 2022;23(8):746\u201353. https:\/\/doi.org\/10.1001\/jama.2022.13044.","journal-title":"JAMA Aug"},{"issue":"6","key":"439_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"12","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Sr., Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation Feb. 2008;12(6):743\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579.","journal-title":"Circulation Feb"},{"issue":"15","key":"439_CR10","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3390\/cancers14153651","volume":"14","author":"RM Alvi","year":"2022","unstructured":"Alvi RM, Quinaglia T, Spahillari A, et al. The prediction of cardiac events using contemporary risk prediction models after radiation therapy for head and neck cancer. Cancers. 2022;14(15):3651.","journal-title":"Cancers"},{"key":"439_CR11","doi-asserted-by":"publisher","unstructured":"Zhang SC, Gasho JO, Eno C et al. Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study. Commun Med. 2025\/02\/17 2025;5(1):43. https:\/\/doi.org\/10.1038\/s43856-025-00761-6.","DOI":"10.1038\/s43856-025-00761-6"},{"issue":"1","key":"439_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5853\/jos.2017.01802","volume":"20","author":"D Addison","year":"2018","unstructured":"Addison D, Lawler PR, Emami H, et al. Incidental Statin use and the risk of stroke or transient ischemic attack after radiotherapy for head and neck cancer. J Stroke. 2018;20(1):71\u20139. https:\/\/doi.org\/10.5853\/jos.2017.01802.","journal-title":"J Stroke"},{"key":"439_CR13","doi-asserted-by":"publisher","unstructured":"Alvi RM, Quinaglia T, Spahillari A, et al. The prediction of cardiac events using contemporary risk prediction models after radiation therapy for head and neck cancer. Cancers. 2022;14(15). https:\/\/doi.org\/10.3390\/cancers14153651.","DOI":"10.3390\/cancers14153651"},{"key":"439_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6205158","author":"CW Hsu","year":"2016","unstructured":"Hsu CW, Huang YB, Kuo CC, Chen CY. Evaluating the primary prevention of ischemic stroke of oral antithrombotic therapy in head and neck cancer patients with radiation therapy. Biomed Res Int. 2016. https:\/\/doi.org\/10.1155\/2016\/6205158.","journal-title":"Biomed Res Int"},{"key":"439_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110067","author":"CY Lin","year":"2024","unstructured":"Lin CY, Chang CL, Lin KC, et al. Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patients. Radiother Oncol. 2024. https:\/\/doi.org\/10.1016\/j.radonc.2023.110067.","journal-title":"Radiother Oncol"},{"issue":"1","key":"439_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijrobp.2023.08.011","volume":"118","author":"ED Miller","year":"2024","unstructured":"Miller ED, Wu T, McKinley G, et al. Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy. Int J Radiat Oncol Biol Phys. 2024;118(1):124\u201336. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.08.011.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"439_CR17","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1016\/j.prro.2020.12.006","volume":"11","author":"KM Atkins","year":"2021","unstructured":"Atkins KM, Bitterman DS, Chaunzwa TL, et al. Statin use, heart radiation dose, and survival in locally advanced lung cancer. Pract Radiat Oncol. 2021;11(5):e459\u201367. https:\/\/doi.org\/10.1016\/j.prro.2020.12.006.","journal-title":"Pract Radiat Oncol"},{"key":"439_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109762","author":"GM Walls","year":"2023","unstructured":"Walls GM, O\u2019Connor J, Harbinson M, et al. Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: results from the NI-HEART study. Radiother Oncol. 2023. https:\/\/doi.org\/10.1016\/j.radonc.2023.109762.","journal-title":"Radiother Oncol"},{"issue":"20","key":"439_CR19","doi-asserted-by":"publisher","first-page":"e036411","DOI":"10.1161\/JAHA.124.036411","volume":"13","author":"YJ Huang","year":"2024","unstructured":"Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY. Statin therapy reduces Radiation-Induced cardiotoxicity in patients with breast cancer receiving adjuvant radiotherapy. J Am Heart Assoc. 2024;13(20):e036411. https:\/\/doi.org\/10.1161\/JAHA.124.036411.","journal-title":"J Am Heart Assoc"},{"key":"439_CR20","doi-asserted-by":"publisher","unstructured":"Boulet J, Pe\u00f1a J, Hulten EA, et al. Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck. J Am Heart Association. 2019;8(13). https:\/\/doi.org\/10.1161\/JAHA.117.005996.","DOI":"10.1161\/JAHA.117.005996"},{"issue":"3","key":"439_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/hed.24646","volume":"39","author":"CC Okoye","year":"2017","unstructured":"Okoye CC, Bucher J, Tatsuoka C, et al. Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy. Head Neck. 2017;39(3):527\u201332. https:\/\/doi.org\/10.1002\/hed.24646.","journal-title":"Head Neck"},{"issue":"3","key":"439_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","volume":"3","author":"JD Mitchell","year":"2021","unstructured":"Mitchell JD, Cehic DA, Morgia M, et al. Cardiovascular manifestations from therapeutic radiation: A multidisciplinary expert consensus statement from the international Cardio-Oncology society. JACC CardioOncol Sep. 2021;3(3):360\u201380. https:\/\/doi.org\/10.1016\/j.jaccao.2021.06.003.","journal-title":"JACC CardioOncol Sep"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00439-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00439-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00439-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:55:58Z","timestamp":1770386158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-025-00439-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00439-x","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}